Measuring Cigarette Smoking-Induced Cortical Dopamine Release: A [11C]FLB-457 PET Study

Neuropsychopharmacology

Volumn 40, Issue 6, 2015, Pages 1417-1427

  Wing, Victoria C ^a   Payer, Doris E ^a,b   Houle, Sylvain ^a   George, Tony P ^a,b   Boileau, Isabelle ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; ISOREMOXIPRIDE; PYRROLIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT; SALICYLAMIDE DERIVATIVE;

ADULT; BRAIN CORTEX; BRAIN MAPPING; CRAVING; DIAGNOSTIC IMAGING; FEMALE; HUMAN; MALE; METABOLISM; PHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PSYCHOLOGY; SMOKING; TOBACCO DEPENDENCE;

ADULT; BRAIN MAPPING; CARBON RADIOISOTOPES; CEREBRAL CORTEX; CRAVING; DOPAMINE; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PYRROLIDINES; RADIOPHARMACEUTICALS; SALICYLAMIDES; SMOKING; TOBACCO USE DISORDER;

EID: 84936819758     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.327     Document Type: Article

References (67)

1. Aalto S, Bruck A, Laine M, Nagren K, Rinne JO (2005). Frontal and temporal dopamine release during working memory and attention tasks in healthy humans: a positron emission tomography study using the high-affinity dopamine D2 receptor ligand [11C]FLB 457. J Neurosci 25: 2471-2477.
2. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y et al (2002). Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22: 3708-3719.
3. Ashare RL, Falcone M, Lerman C (2014). Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology 76(Pt B): 581-591.
4. Asselin MC, Montgomery AJ, Grasby PM, Hume SP (2007). Quantification of PET studies with the very high-affinity dopamine D2/D3 receptor ligand [11C]FLB 457: re-evaluation of the validity of using a cerebellar reference region. J Cereb Blood Flow Metab 27: 378-392.
5. Azizian A, Nestor LJ, Payer D, Monterosso JR, Brody AL, London ED (2010). Smoking reduces conflict-related anterior cingulate activity in abstinent cigarette smokers performing a Stroop task. Neuropsychopharmacology 35: 775-782.
6. Barrett SP, Boileau I, Okker J, Pihl RO, Dagher A (2004). The hedonic response to cigarette smoking is proportional to dopamine release in the human striatum as measured by positron emission tomography and [11C]raclopride. Synapse 54: 65-71.
7. Beck AT, Steer RA, Ball R, Ranieri W (1996). Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 67: 588-597.
8. Bernert JT Jr., Turner WE, Pirkle JL, Sosnoff CS, Akins JR, Waldrep MK et al (1997). Development and validation of sensitive method for determination of serum cotinine in smokers and nonsmokers by liquid chromatography/atmospheric pressure ionization tandem mass spectrometry. Clin Chem 43: 2281-2291.
9. Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA et al (2014). In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Mol Psychiatry 19: 1305-1313.
10. Brody AL, Mandelkern MA, London ED, Childress AR, Lee GS, Bota RG et al (2002). Brain metabolic changes during cigarette craving. Arc Gen Psychiatry 59: 1162-1172.
11. Brody AL, Mandelkern MA, Olmstead RE, Allen-Martinez Z, Scheibal D, Abrams AL et al (2009). Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology 34: 282-289.
12. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P et al (2004). Smoking-induced ventral striatum dopamine release. Am J Psychiatry 161: 1211-1218.
13. Castner SA, Goldman-Rakic PS (2004). Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation. J Neurosci 24: 1446-1450.
14. Delforge J, Bottlaender M, Loc'h C, Guenther I, Fuseau C, Bendriem B et al (1999). Quantitation of extrastriatal D2 receptors using a very high-affinity ligand (FLB 457) and the multi-injection approach. J Cereb Blood Flow Metab 19: 533-546.
15. Di Chiara G (2000). Role of dopamine in the behavioural actions of nicotine related to addiction. Eur J Pharmacology 393: 295-314.
16. Domino EF, Tsukada H (2009). Nicotine sensitization of monkey striatal dopamine release. Eur J Pharmacology 607: 91-95.
17. First MB, Spitzer RL, Gibbon M, Williams JBW (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV) Washington, D.C.: American Psychiatric Press, Inc.
18. Gallezot JD, Kloczynski T, Weinzimmer D, Labaree D, Zheng MQ, Lim K et al (2014). Imaging nicotine- and amphetamine-induced dopamine release in rhesus monkeys with [(11)C]PHNO vs [(11)C]raclopride PET. Neuropsychopharmacology 39: 866-874.
19. Garris PA, Wightman RM (1994). Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex, and striatum: an in vivo voltammetric study. J Neuroscience 14: 442-450.
20. George TP, Verrico CD, Picciotto MR, Roth RH (2000). Nicotinic modulation of mesoprefrontal dopamine neurons: pharmacologic and neuroanatomic characterization. J Pharmacol Exper Ther 295: 58-66.
21. Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997). Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. NeuroImage 6: 279-287.
22. Halldin C, Farde L, Hogberg T, Mohell N, Hall H, Suhara T et al (1995). Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors. J Nuclear Med 36: 1275-1281.
23. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO (1991). The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict 86: 1119-1127.
24. Heishman SJ, Kleykamp BA, Singleton EG (2010). Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 210: 453-469.
25. Hughes JR, Hatsukami D (1986). Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 43: 289-294.
26. Ito H, Sudo Y, Suhara T, Okubo Y, Halldin C, Farde L (2001). Error analysis for quantification of [(11)C]FLB 457 binding to extrastriatal D(2) dopamine receptors in the human brain. NeuroImage 13: 531-539.
27. Janes AC, Pizzagalli DA, Richardt S, de BFB, Chuzi S, Pachas G et al (2010a). Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence. Biol Psychiatry 67: 722-729.
28. Janes AC, Pizzagalli DA, Richardt S, Frederick Bde B, Holmes AJ, Sousa J et al (2010b). Neural substrates of attentional bias for smoking-related cues: an FMRI study. Neuropsychopharmacology 35: 2339-2345.
29. Janes AC, Ross RS, Farmer S, Frederick BB, Nickerson LD, Lukas SE et al (2013). Memory retrieval of smoking-related images induce greater insula activation as revealed by an fMRI-based delayed matching to sample task. Addict Biol doi:10.1111/adb.12112; e-pub ahead of print.
30. Kim SE, Han SM (2009). Nicotine- and methamphetamine-induced dopamine release evaluated with in-vivo binding of radiolabelled raclopride to dopamine D2 receptors: comparison with in-vivo microdialysis data. Int J Neuropsychopharmacol 12: 833-841.
31. Ko JH, Ptito A, Monchi O, Cho SS, Van Eimeren T, Pellecchia G et al (2009). Increased dopamine release in the right anterior cingulate cortex during the performance of a sorting task: a [11C]FLB 457 PET study. NeuroImage 46: 516-521.
32. Lammertsma AA, Hume SP (1996). Simplified reference tissue model for PET receptor studies. NeuroImage 4(3 Pt 1): 153-158.
33. Laruelle M (2000). Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 20: 423-451.
34. Le Foll B, Guranda M, Wilson AA, Houle S, Rusjan PM, Wing VC et al (2014). Elevation of dopamine induced by cigarette smoking: novel insights from a [(11)C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 39: 415-424.
35. Levin ED, McClernon FJ, Rezvani AH (2006). Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization. Psychopharmacology (Berl) 184: 523-539.
36. Lieberman MD, Cunningham WA (2009). Type I and type II error concerns in fMRI research: re-balancing the scale. Soc Cogn Affect Neurosci 4: 423-428.
37. Livingstone PD, Srinivasan J, Kew JNC, Dawson LA, Gotti C, Moretti M et al (2009). alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex. Eur J Neurosci 29: 539-550.
38. Loughead J, Wileyto EP, Valdez JN, Sanborn P, Tang K, Strasser AA et al (2009). Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol Psychiatry 14: 820-826.
39. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH (2003). An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 19: 1233-1239.
40. Mansvelder HD, De Rover M, McGehee DS, Brussaard AB (2003). Cholinergic modulation of dopaminergic reward areas: upstream and downstream targets of nicotine addiction. Eur J Pharmacol 480: 117-123.
41. Marenco S, Carson RE, Berman KF, Herscovitch P, Weinberger DR (2004). Nicotine-induced dopamine release in primates measured with [11C]raclopride PET. Neuropsychopharmacology 29: 259-268.
42. Marshall DL, Redfern PH, Wonnacott S (1997). Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 68: 1511-1519.
43. Mukherjee J, Yang ZY, Das MK, Brown T (1995). Fluorinated benzamide neuroleptics-III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2, 3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer. Nuclear Med Biol 22: 283-296.
44. Nagano-Saito A, Dagher A, Booij L, Gravel P, Welfeld K, Casey KF et al (2013). Stress-induced dopamine release in human medial prefrontal cortex-18F-fallypride/PET study in healthy volunteers. Synapse 67: 821-830.
45. Narendran R, Frankle WG, Mason NS, Rabiner EA, Gunn RN, Searle GE et al (2009). Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: a comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride. Synapse 63: 447-461.
46. Narendran R, Himes M, Mason NS (2013). Reproducibility of postamphetamine [11C]FLB 457 binding to cortical D2/3 receptors. PloS One 8: e76905.
47. Narendran R, Jedema HP, Lopresti BJ, Mason NS, Gurnsey K, Ruszkiewicz J et al (2014). Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [(11)C]FLB 457 PET study. Mol Psychiatry 19: 399.
48. Narendran R, Mason NS, Chen CM, Himes M, Keating P, May MA et al (2011a). Evaluation of dopamine D(2)/(3) specific binding in the cerebellum for the positron emission tomography radiotracer [(1)(1)C]FLB 457: implications for measuring cortical dopamine release. Synapse 65: 991-997.
49. Narendran R, Mason NS, May MA, Chen CM, Kendro S, Ridler K et al (2011b). Positron emission tomography imaging of dopamine D(2)/(3) receptors in the human cortex with [(1)(1)C]FLB 457: reproducibility studies. Synapse 65: 35-40.
50. Olsson H, Halldin C, Farde L (2004). Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET. NeuroImage 22: 794-803.
51. Paulson PE, Robinson TE (1994). Relationship between circadian changes in spontaneous motor activity and dorsal versus ventral striatal dopamine neurotransmission assessed with on-line microdialysis. Behav Neurosci 108: 624-635.
52. Rusjan P, Mamo D, Ginovart N, Hussey D, Vitcu I, Yasuno F et al (2006). An automated method for the extraction of regional data from PET images. Psychiatry Res 147: 79-89.
53. Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S et al (2005). Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch Gen Psychiatry 62: 649-659.
54. Schilstrom B, Nomikos GG, Nisell M, Hertel P, Svensson TH (1998). N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82: 781-789.
55. Sesack SR, Grace AA (2009). Cortico-basal ganglia reward network: microcircuitry. Neuropsychopharmacology 35: 27-47.
56. Shotbolt P, Tziortzi AC, Searle GE, Colasanti A, van der Aart J, Abanades S et al (2012). Within-subject comparison of [(11)C]- (+)-PHNO and [(11)C]raclopride sensitivity to acute amphetamine challenge in healthy humans. J Cereb Blood Flow Metab 32: 127-136.
57. Sobell LC, Sobell MB, Leo GI, Cancilla A (1988). Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations. Br J Addict 83: 394-402.
58. Sudo Y, Suhara T, Inoue M, Ito H, Suzuki K, Saijo T et al (2001). Reproducibility of [11 C]FLB 457 binding in extrastriatal regions. Nuclear Med Commun 22: 1215-1221.
59. Tiffany ST, Drobes DJ (1991). The development and initial validation of a questionnaire on smoking urges. Br J Addict 86: 1467-1476.
60. Vilkman H, Kajander J, Nagren K, Oikonen V, Syvalahti E, Hietala J (2000). Measurement of extrastriatal D2-like receptor binding with [11C]FLB 457-a test-retest analysis. Eur J Nuclear Med 27: 1666-1673.
61. Williams SM, Goldman-Rakic PS (1998). Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex 8: 321-345.
62. Wing VC, Tang YL, Sacco KA, Cubells JF, George TP (2013a). Effect of COMT Val(158)Met genotype on nicotine withdrawalrelated cognitive dysfunction in smokers with and without schizophrenia. Schizophr Res 150: 602-603.
63. Wing VC, Wass CE, Bacher I, Rabin RA, George TP (2013b). Varenicline modulates spatial working memory deficits in smokers with schizophrenia. Schizophr Res 149: 190-191.
64. Wing VC, Wass CE, Soh DW, George TP (2012). A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Ann N Y Acad Sci 248: 89-106.
65. Wood DM, Mould MG, Ong SB, Baker EH (2005). "Pack year"smoking histories: what about patients who use loose tobacco? Tob Control 14: 141-142.
66. Zachary RA, Paulson MJ, Gorsuch Y (1985). Estimating WAIS IQ from the Shipley Institute of Living Scale using continuously adjusted age norms. J Clin Psychol 41: 820-831.
67. Zubieta JK, Heitzeg MM, Xu Y, Koeppe RA, Ni L, Guthrie S et al (2005). Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. Am J Psychiatry 162: 567-577.